Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00389025
NCT00389025CompletedPhase 4

Mast-Cell Stabilizing Effects of Olopatadine

Alcon Research1 site in 1 country24 target enrollmentStarted: October 2006Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
24
Locations
1
Primary Endpoint
Tear histamine
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

To assess the effects of olopatadine of the release of mast cell histamine

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
Double

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Asymptomatic and not using any topical or systemic medication

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Tear histamine

Secondary Outcomes

  • Tear cytology, subject evaluation of ocular itching, investigators evaluation of ocular redness

Investigators

Sponsor Class
Industry

Study Sites (1)

Loading locations...

Similar Trials

Active, not recruiting
Not Applicable
Clinical study of the mast-cell stabilizing effects of the Olopatadine using the Conjunctival Allergen Challeenge model - ND
EUCTR2005-004768-22-ITALCON ITALIA25
Completed
Phase 2
KUL0401: An Open-label Pilot Study of Oxatomide in Steroid-Naive Duchenne Muscular DystrophyMuscular Dystrophy, Duchenne
NCT00033813Cooperative International Neuromuscular Research Group15
Completed
Early Phase 1
Mast Cells in Male Pelvic Pain and and Lower Urinary Tract DysfunctionChronic Prostatitis With Chronic Pelvic Pain Syndrome
NCT03167216Northwestern University20
Recruiting
Unknown
Investigation of mast cell-stimulating factors using blood from subjects with chronic spontaneous urticariaChronic spontaneous urticariaD000080223
JPRN-jRCT1030230097Hayama Koremasa35
Recruiting
Not Applicable
Effects of ebastine on up-regulation of histamine H1 receptor mRNA in the nasal mucosa induced by artificial exposure of Japanese cedar pollen in patients with allergic rhinitis to cedar pollen.allergic rhinitis
JPRN-UMIN000008951niversity of Tokushima40